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Abstract The functional coupling of C-terminally truncated
mutants of the high affinity rat neurotensin (NT) receptor
(NTS1) was characterized in transfected Chinese hamster ovary
cells. On cells expressing NTRv372 (truncated NTS1 lacking
the entire 52 amino acid C-terminus), NT failed to promote
[35S]guanosine 5P-[Q-35S]triphosphate binding whereas a robust
pertussis toxin (PTx) sensitive response was observed in cells
expressing a partially truncated receptor (NTRv401 lacking the
last 23 residues). Similar results were obtained when measuring
the ability of NT to induce the production of arachidonic acid.
Since neither deletions impaired the NT-induced phosphoinosi-
tide hydrolysis, these results indicate that the membrane
proximal region of the C-terminus is specifically involved in
the functional coupling of the receptor with PTx sensitive
G-proteins. This region was also found to be involved in the
control of receptor internalization. However, PTx failed to
impair internalization, indicating that these two properties are
not directly related. ß 2002 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
In contrast to the simple, initially proposed, paradigm that
a given G-protein coupled receptor (GPCR) interacts with a
particular G-protein or to various G-proteins within one fam-
ily, it is now well documented that simultaneous functional
coupling with distinct unrelated G-proteins can be observed.
Thus evidence for dual coupling to Gs and Gq type G-pro-
teins [1^3] or to Gi and Gq type G-proteins [4^6] has been
reported in a variety of cellular and tissular models. The im-
portance of this genuine property of GPCRs was further re-
vealed in recent studies showing that the coupling to multiple
signaling pathways was dependent on the agonist used [7^11],
showed distinct desensitization kinetics [12,13] and involved
distinct molecular determinants of the receptor [14].
Most studies have highlighted the functional coupling of
high a⁄nity neurotensin (NT) receptor (NTS1) with phospho-
lipase C (PLC), supporting evidence for the involvement of
protein kinase C activation and inositol phosphate (InsP) de-
pendent mobilization of intracellular calcium in the cellular
responses to NT (for review, see [15]). However, we have
previously shown that in transfected Chinese hamster ovary
(CHO) cells, NT mediates a robust increase in guanosine-5P-
O-(3-[35S]thio)triphosphate ([35S]GTPQS) binding [16], an ef-
fect that is generally considered to reveal the functional cou-
pling with Gi/o type G-proteins [17^19]. Accordingly, the re-
sponse to NT is almost fully inhibited after pertussis toxin
(PTx) treatment [20]. Based on these observations and from
studies conducted with NTS1/GK protein fusions expressed in
Escherichia coli [21], we previously proposed a dual coupling
of this receptor with both Gq and Gi/o type G-proteins.
Whereas Gq protein mediates the well documented NT-in-
duced InsP production and calcium mobilization, Gi/o pro-
teins contribute to the NT-mediated activation of phospholi-
pase A2 (PLA2) [20]. By evaluating the ability of C-terminally
truncated NTS1 mutants in mediating [35S]GTPQS binding,
PLA2 and PLC activation, we now provide evidence for the
involvement of distinct regions of the receptor in the func-
tional coupling with PTx sensitive (presumably of the Gi/o
family) and insensitive (Gq) G-proteins.
2. Materials and methods
2.1. Materials
All culture media and materials were from Life Technologies.
[35S]GTPQS (speci¢c activity 1000 Ci/mmol), [3H]arachidonic acid
(100 Ci/mmol) and [3H]NT (101 Ci/mmol) were from NEN-Dupont,
and myo-[2-3H]inositol (70^120 Ci/mmol) was from Amersham. PTx,
NT, 1,10-phenanthroline, dithiothreitol (DTT) and 5P-guanylylimido-
diphosphate (Gpp(NH)p) were from Sigma.
2.2. Expression of truncated mutants of the rat NTS1 in CHO cells
The molecular cloning of the cDNA sequence encoding the rat
NTS1 in the expression vector pSVK3 (Pharmacia Biotech) has
been previously described [22]. The cDNAs encoding the truncated
receptors were obtained by polymerase chain reaction (PCR) per-
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formed on the rat NTS1 full length cDNA. The 5P-oligonucleotide (5P-
GAATTCGAATTCCCGGCACCCACCATGCACCTCAA-3P) corre-
sponded to the 5P-end sequence of NTS1 cDNA and contained an
EcoRI restriction site, the 3P-oligonucleotides (5P-TCTAGATCTA-
GACCAGGTTGTAGAGGATGGGATT-3P and 5P-GGGCTTCCT-
CTAGAACGTTGGCCTCTTTCGG-3P) were complementary to nu-
cleotides 1092^1126 and 1181^1212 of NTS1 cDNA, respectively, and
contained an XbaI site and an in frame stop codon. The PCR prod-
ucts (corresponding to amino acids 1^372 and 1^401, respectively, i.e.
lacking the last 52 and 23 amino acids, respectively) were cloned in
pSVK3.
CHO cells were cultured in modi¢ed Eagle’s medium (MEM) K
medium supplemented with 10% fetal calf serum, 85 Wg/ml streptomy-
cin and 85 U/ml penicillin at 37‡C in a humidi¢ed atmosphere of 5%
CO2^95% air. Cells were co-transfected with the NTS1 constructs
cloned in pSVK3 together with pSV2neo encoding the geneticin-resis-
tant gene (9/1 ratio) by the calcium phosphate co-precipitation meth-
od. Transfected cells were selected in the presence of 600 Wg/ml genet-
icin and resistant cell populations were submitted to limited dilutions
in order to isolate cellular clones. Clones that displayed similar
[3H]NT speci¢c binding were used in the present study. Transfected
CHO cells were routinely cultured in the above mentioned medium
supplemented with 150 Wg/ml geneticin. When indicated, 100 ng/ml
PTx was added in the culture medium 20 h before the experiment.
2.3. Binding of [35S]GTPQS and [3H]NT
The speci¢c binding of [35S]GTPQS (0.1 nM) and [3H]NT (0.0625^2
nM) was measured on cell homogenates (25^50 Wg protein/tube) in a
bu¡er containing 50 mM Tris^HCl pH 7.4 containing 5 mM MgCl2,
1 WM 1,10-phenanthroline and 0.1% bovine serum albumin (BSA), as
previously described [20]. For [35S]GTPQS binding studies, this bu¡er
was also supplemented with 1 WM GDP, 150 mM NaCl and 1 mM
DTT. The e¡ect of guanylyl nucleotides on the a⁄nity of [3H]NT was
measured by comparing saturation curves of [3H]NT speci¢c binding
performed in the presence or in the absence of 100 WM Gpp(NH)p.
2.4. Measurement of [3H]InsP and arachidonic acid release
The ability of NT to mediate PLC activation was evaluated by
measuring the accumulation of [3H]InsP in intact cells in the presence
of 10 mM LiCl ion. Sample extraction and analysis of the [3H]InsP
fraction were performed as previously described [20]. NT-induced
[3H]arachidonic acid release was measured on cells grown in the pres-
ence of 0.5 pCi/well [3H]arachidonic acid for 24 h as previously de-
scribed [23].
2.5. Internalization of [3H]NT
Receptor-mediated internalization of [3H]NT was measured on in-
tact cells by measuring the proportion of radioactivity that remained
associated with the cells after acid-stripping of cell surface bound
ligand [24^26]. Cells were grown to con£uence in 24-well plates.
Shortly, after washing with incubation bu¡er (Ham/F12 supplemented
with 1 WM 1,10-phenanthroline and 0.1% BSA), cells were incubated
in the same bu¡er for 15 min at 37‡C. Thereafter, medium was re-
placed with fresh medium containing 1 nM [3H]NT (with or without
1 WM unlabeled NT for determination of the non-speci¢c binding).
After incubation at 37‡C for the period of time indicated, cells were
placed on ice and washed rapidly once with ice cold neutral phos-
phate-bu¡ered saline (PBS) (pH 7.4) and twice with either ice cold
neutral PBS (for measurement of total and non-speci¢c binding) or
acidic PBS pH 2.5 (to measure internalized peptide). After a ¢nal
wash with neutral PBS, cells were dissolved in 1% sodium deoxycho-
late (pH 11.3) and radioactivity was counted by liquid scintillation.
Percentage of internalization was expressed as the ratio of acidic-re-
sistant binding/speci¢c binding.
3. Results
Truncated forms of NTS1 lacking either the last 23 (clone
NTRv401) or 52 (clone NTRv372) residues were expressed in
transfected CHO cells (Fig. 1). The mutated DNA sequences
were obtained by PCR with speci¢c oligonucleotides designed
in order to introduce termination codons within the cDNA
sequence encoding the intracellular C-terminus of the recep-
tor, yielding truncated receptors. Clones expressing similar
levels of the wild-type or the mutated receptors were selected
and further characterized. As shown in Table 1, the a⁄nity of
[3H]NT measured on homogenates from cells expressing trun-
cated receptor was not signi¢cantly di¡erent from that mea-
sured on transfected CHO cells expressing the rat NTS1
(CHO-NTRwt cells). As commonly observed with most
GPCRs, the a⁄nity of NT for its receptor is dependent on
the functional coupling with G-protein, and disruption of this
coupling with guanylyl nucleotides decreases the binding af-
¢nity. Addition of Gpp(NH)p signi¢cantly decreased the af-
¢nity of [3H]NT for the wild-type receptor expressed in CHO
cells, whereas such e¡ect was not observed after truncation of
the entire C-terminus (Table 1). In contrast, the binding of
[3H]NT to CHO-NTRv401 was decreased in the presence of
Gpp(NH)p in a similar fashion to what is observed with the
wild-type receptor. Taken together, these results indicate that
the membrane proximal region of NTS1 is required in order
to pharmacologically reveal disruption of G-protein coupling
with guanylyl nucleotides.
In both CHO-NTRv372 and CHO-NTRv401 cells, NT-in-
duced phosphoinositide hydrolysis with a similar potency to
that observed in CHO-NTRwt (pEC50 values were 9.10 þ 0.14,
8.99 þ 0.13 and 9.43 þ 0.13 for CHO-NTRwt, CHO-NTRv372
and CHO-NTRv401, respectively) (Fig. 2A). The maximal
response was found to be signi¢cantly higher (Student t-test)
in cells expressing the truncated receptors as compared to
those expressing the wild-type receptor (32% higher for
CHO-NTRv372, P6 0.05 and 126% higher for CHO-
NTRv401, P6 0.001).
Using optimized experimental conditions, we previously
showed that in homogenates of transfected CHO cells express-
ing NTS1, NT induces a robust increase in [35S]GTPQS bind-
ing [16]. We recently showed that this response mainly re£ects
the functional activation of PTx-sensitive G-proteins, presum-
ably Gi [20,21]. The ability of NT to promote [35S]GTPQS
Table 1
Characterization of [3H]NT speci¢c binding on membranes of transfected CHO cells expressing NTRwt, NTRv372 or NTRv401
Clone KD (nM) BMax (pmol/mg protein) n
CHO-NTRwt 0.24 þ 0.05 0.98 þ 0.06 5
CHO-NTRwt+Gpp(NH)p 100 WM 0.91 þ 0.06*** 0.82 þ 0.16 5
CHO-NTRv372 0.20 þ 0.02 1.60 þ 0.42 4
CHO-NTRv372+Gpp(NH)p 100 WM 0.32 þ 0.04n:s: 1.73 þ 0.53 4
CHO-NTRv401 0.23 þ 0.04 1.49 þ 0.16 4
CHO-NTRv401+Gpp(NH)p 100 WM 1.26 þ 0.17*** 1.05 þ 0.14 4
The speci¢c binding of [3H]NT (0.06^2 nM) was measured on cell homogenates in the presence or in the absence of 100 WM Gpp(NH)p. Data
indicated are KD and Bmax values determined by non-linear analysis of the saturation curves and are mean þ S.E.M. from n di¡erent experi-
ments performed in duplicate. The in£uence of Gpp(NH)p on the KD of [3H]NT was statistically analyzed by one way ANOVA followed by
Newman^Keuls test (***P6 0.001; n.s., non-signi¢cant).
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binding was used to examine the functional coupling of
truncated NTS1s with Gi/o-type G-proteins when expressed
in CHO cells. As shown in Fig. 2B, NT-induced nucleotide
binding was almost not detected in CHO-NTRv372 cells,
whereas in CHO-NTRv401 cells, the response to NT was
identical to that obtained in CHO-NTRwt cells (non-signi¢-
cant di¡erence between the potency and e⁄cacy of NT,
see legend of Fig. 2B). As previously reported for cells
expressing the wild-type receptor, NT-induced [35S]GTPQS
binding was almost undetectable on PTx-pretreated CHO-
NTRv401 cells.
In a variety of models, including transfected CHO cells, NT
was shown to activate PLA2, causing the release of arachi-
donic acid [20]. Although calcium mobilization appears to
enhance this response, we showed that NT-mediated arachi-
donic acid release mainly results from the coupling with PTx-
sensitive G-proteins. In cells expressing the partially truncated
receptor (CHO-NTRv401), NT induced a robust increase in
arachidonic acid release that was indistinguishable from that
measured in CHO-NTRwt cells and completely suppressed
after PTx treatment. In contrast, no such functional response
was detected in CHO-NTRv372 cells (Fig. 2C). Together,
these results indicate that the membrane proximal region of
the NTS1 C-terminus plays a critical role for both NT-in-
duced [35S]GTPQS binding and NT-induced arachidonic acid
release whereas the conservation of the more distal region is
not absolutely required.
Incubation of transfected CHO cells expressing NTS1 with
NT is followed by the internalization of the peptide through
receptor-mediated internalization. CHO-NTRwt cells rapidly
internalize [3H]NT (up to 90% internalization after 30 min, see
Fig. 3A), whereas a dramatic decrease in the rate of internal-
ization is observed after truncation of the entire C-terminus of
the receptor (CHO-NTRv372, less than 40% internalization
after 30 min). In contrast, although the rate of internalization
was lower than in CHO-NTRwt cells, a robust [3H]NT inter-
nalization (up to V80% after 30 min) was measured in cells
expressing NTRv401. These results indicate that within the
C-terminus of NTS1, the membrane proximal region is in-
Fig. 1. Proposed structure of NTS1 and detail of the amino acid se-
quence of the C-terminus in the wild-type receptor (NTRwt) and
the truncated receptors examined in the present study.
Fig. 2. A: NT-induced [3H]InsP accumulation in CHO-NTRwt,
CHO-NTRv372 and CHO-NTRv401 cells. Data shown are
mean þ S.E.M. from at least ¢ve di¡erent experiments performed in
triplicate. B: NT-induced [35S]GTPQS binding on homogenates from
CHO-NTRwt, CHO-NTRv372 and CHO-NTRv401 cells. The po-
tency (pEC50) of NT in CHO-NTRwt and CHO-NTRv401 was de-
termined by non-linear analysis of sigmoidal concentration response
curves and revealed no signi¢cant di¡erence (8.20 þ 0.11 and
8.20 þ 0.07, respectively). Data shown with open symbols and dotted
line indicate the responses measured on cells previously treated in
with PTx (100 ng/ml, 20 h). Data are mean þ S.E.M. from at least
six (no PTx) or two (with PTx) di¡erent experiments performed in
duplicate. C: NT (10 nM)-induced arachidonic acid production.
Data shown are mean þ S.E.M. from four to 22 di¡erent determina-
tions.
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volved in the control of receptor-mediated peptide internal-
ization. In order to evaluate the in£uence of NTS1 coupling
with PTx sensitive G-proteins, internalization of [3H]NT was
measured in CHO-NTRwt cells previously treated with PTx.
As shown on Fig. 3B, PTx pretreatment had no signi¢cant
e¡ect on the ability of the cells to internalize [3H]NT.
4. Discussion
On the basis of the numerous studies aiming at depicting
the molecular basis of receptor/G-protein coupling, it becomes
more and more evident that no consensus model will ever be
proposed for de¢ning the structural features that determine
the possible coupling of hundreds of receptors with dozens of
G-proteins (for review, see [27]). Moreover, functional cou-
pling is probably coordinated by several di¡erent regions of
the receptor. In the case of the rat NTS1, previous studies
have shown that partial deletions within its third intracellular
loop completely prevented the coupling with PLC [28]. The
speci¢c involvement of this region of the receptor in the cou-
pling with Gq type G-protein is con¢rmed by showing that
partial or total deletion of the C-terminus did not impair NT-
mediate InsPs accumulation. Intriguingly this response was
higher with C-terminally truncated receptor, in accordance
with previous studies showing that many GPCR more e⁄-
ciently activate PLC after deletion of their C-terminus which
is proposed to contain inhibitory sequences [29^31].
Both NT-induced [35S]GTPQS binding, and arachidonic acid
production were almost undetectable in cells expressing the
receptor lacking its entire intracellular C-terminus. In con-
trast, cells expressing a partially truncated receptor responded
to NT with the same e⁄cacy and potency as compared to cell
expressing the wild-type receptor. Furthermore, in cells ex-
pressing the NTRwt or NTRv401, [35S]GTPQS binding and
arachidonic acid production were prevented after treatment of
the cells with PTx. Together, these data indicate that the
membrane proximal region of the NTS1 intracellular C-termi-
nus (residues 373^401) is involved in its functional coupling
with PTx sensitive G-proteins.
Functional interaction of a receptor with G-proteins is also
frequently examined by testing the e¡ect of non-hydrolysable
guanylyl nucleotides on the agonist binding. These nucleotides
disrupt the ternary complex (agonist/receptor/G protein) and
thereby decrease the a⁄nity of agonists. According to other
studies conducted on various tissular and cellular models, the
a⁄nity of NT for NTS1s is signi¢cantly decreased in the pres-
ence of Gpp(NH)p [20,32^34]. The binding of NT was modu-
lated by Gpp(NH)p on cells expressing the partially truncated
NTS1 while no similar e¡ect was observed after deletion of
the entire intracellular C-terminus, indicating that the mem-
brane proximal region of the intracellular C-terminus plays a
crucial role in determining the sensitivity of agonist binding to
G-protein coupling. It is noteworthy that [3H]NT binding ex-
periments conducted on CHO-NTRv372 cell homogenates
both in the presence or in the absence of guanylyl nucleotide
revealed ‘high a⁄nity state’ binding. This suggests that the
lack of e¡ect of Gpp(NH)p is not indicative of a disrupted
G-protein coupling, but rather indicates that removal of the
entire C-terminus constrains the receptor in the high-a⁄nity
conformation, irrespective of G-protein coupling.
As many GPCRs, NTS1 is subject to agonist-induced reg-
ulation through rapid signaling desensitization, receptor inter-
nalization and down regulation (for review, see [15]). In many
models, including transfected CHO cells, NT was shown to be
rapidly internalized through receptor-mediated endocytosis.
Although we previously showed that deletion of the entire
intracellular C-terminus of NTS1 dramatically impaired NT
internalization [25]. The present data indicate that a partial
truncation modestly a¡ected the rate and amplitude of NT
internalization, revealing that the membrane proximal region
of the C-terminus was playing a critical role in mediating
receptor internalization. Although this coincides with the re-
gion of the receptor involved in Gi/o coupling, pretreatment
of CHO-NTRwt with PTx did not alter the internalization
process, indicating that activation of this subset of G-proteins
and downstream functional responses, including PLA2 activa-
tion, does not control receptor internalization. Therefore,
although the membrane proximal region of the NTS1 C-ter-
minus is clearly involved in the coupling with PTx-sensitive
G-proteins and in the control of receptor internalization, these
two processes appear not to be mechanistically related. Pre-
vious studies have indicated that the NT-mediated activation
of PLC was neither required [28] nor su⁄cient [25] to observe
receptor internalization.
In conclusion, the present study indicates that the dual
coupling of NTS1 with PTx sensitive (presumably of the
Gi/o family) and insensitive (Gq/11) G-proteins requires dis-
tinct molecular determinants of the receptor. This con¢rms
our previous ¢ndings suggesting that the multiple responses
triggered by NT are the consequence of independent signaling
cascades. It also shows that some regions involved in G-pro-
tein coupling are also involved in the control of the receptor
regulation triggered by agonist stimulation. These observa-
tions suggest the possibility of developing agonists able to
induce di¡erent receptor conformations mediating distinct re-
sponses. It also raises the question whether these multiple
signaling pathways could be di¡erentially regulated during
agonist stimulation.
Fig. 3. A: Receptor-mediated internalization of [3H]NT in intact
CHO-NTRwt, CHO-NTRv372 and CHO-NTRv401 cells. After in-
cubation with [3H]NT (1 nM) for the periods of time indicated, cells
were washed three times with either neutral PBS or acidic PBS. Per-
centage of internalization was expressed as the fraction of acidic-re-
sistant speci¢c binding. Internalization data obtained in cells ex-
pressing the truncated receptors were compared with the
corresponding values obtained from CHO-NTRwt cells by one way
ANOVA followed by Newman^Keuls test (***P6 0.001). B: E¡ect
of PTx pretreatment (100 ng/ml, 20 h) on [3H]NT internalization in
intact CHO-NTRwt cells (n.s., non-signi¢cant di¡erence between
corresponding values measured on untreated cells).
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